Datar Cancer Genetics Unveils Exacta AI: A Revolutionary AI-Driven Cancer Treatment Platform

Metropolis Healthcare Partners with Roche to Launch Self-Sampling HPV DNA Test for Cervical Cancer Screening in India

Union Budget 2025: Full Exemption from Basic Customs Duty (BCD) for 36 Lifesaving Drugs

Dr. Jitendra Singh Inaugurates Centre for Advanced Genomics & Precision Medicine at AIIMS Jammu

Union Budget 2025-26: Key Healthcare Measures for Cancer Care and Access to Life-Saving Drugs

FDA Approves Roche’s PATHWAY HER2 Test for Identifying HER2-Ultralow Breast Cancer Patients Eligible for ENHERTU

Bristol Myers Squibb’s Breyanzi® Receives CHMP Recommendation for Relapsed or Refractory Follicular Lymphoma in the EU

NHS to Offer Groundbreaking Gene Therapy for Sickle Cell Disease

Quibim Secures $50M Series A to Advance AI-Powered Imaging for Precision Medicine

Apollo Hospitals Unveils Advanced Oncology Facility in Chennai

Beckman Coulter’s Alzheimer’s Blood Test Receives FDA Breakthrough Device Designation

ANGLE Announces Breakthrough Dual CTC-DNA and ctDNA Analysis with Illumina’s NGS Solution

Diatech Pharmacogenetics and Merck Expand Collaboration to Enhance RAS Biomarker Testing in MEA Region

DCG Unveils AI-Powered Video-Reporting for Personalized Chemotherapy Selection

FDA Approves Monthly Maintenance Dosing for LEQEMBI® in Alzheimer’s Treatment

Home
/
update
/
details

Dhananjay Singh Named Managing Director of Merck India’s Life Science Business

NextEdge Admin

06 Apr 2024

3 min 16 sec

Merck, a leading science and technology company, has appointed Dhananjay Singh as the Managing Director of Merck Life Science in India, effective April 1, 2024. Singh’s appointment marks a significant milestone in his career, as he continues to hold the position of Head of Science & Lab Solutions Commercial, India. He succeeds Sreenath NS, who retired after a distinguished 36-year tenure with Merck in India.

Singh brings to his new role 26 years of invaluable experience with Merck, during which he has played a pivotal role in shaping the Science and Lab Solutions Commercial business in India. His steadfast commitment to advancing scientific progress in collaboration with customers has been exemplary. Singh’s deep understanding of market dynamics and adeptness in managing multi-stakeholder relationships are viewed as instrumental in bolstering Merck Life Science’s foothold in the Indian market.

In his expanded capacity as Managing Director, Singh will spearhead the Life Science strategy in India, ensuring robust governance and compliance in conjunction with other leaders from Merck’s diverse businesses in the country. His journey with Merck began in 1997 at Sigma-Aldrich, where he steadily ascended through various leadership roles within the Commercial Organization, ultimately culminating in his appointment as Head of Science & Lab Solutions Commercial for India in 2022.

Singh expressed his enthusiasm for driving collective efforts towards achieving unparalleled success. He underscored Merck’s unwavering commitment to meeting customer demands through a strategic focus on ‘India for India and India for the Globe.’ Singh’s vision entails navigating the intricacies of the life sciences industry in India while staunchly supporting government initiatives such as “Make in India” to foster growth and innovation.

Under Singh’s stewardship, Merck aims to harness its strong partnerships with customers and its dedicated team to realize its objectives and contribute meaningfully to India’s scientific and economic advancement. His leadership is poised to steer Merck Life Science towards continued growth and success, reinforcing the company’s position as a key player in India’s burgeoning life sciences landscape.